278 related articles for article (PubMed ID: 23121096)
21. Ion channel modulators and urinary tract function.
Brading AF; Brain KL
Handb Exp Pharmacol; 2011; (202):375-93. PubMed ID: 21290236
[TBL] [Abstract][Full Text] [Related]
22. [Animal toxins and ion channels].
Darbon H
J Soc Biol; 1999; 193(6):445-50. PubMed ID: 10783702
[TBL] [Abstract][Full Text] [Related]
23. Ion channels as novel therapeutic targets in the treatment of pain.
Mathie A
J Pharm Pharmacol; 2010 Sep; 62(9):1089-95. PubMed ID: 20796186
[TBL] [Abstract][Full Text] [Related]
24. Ion channels in key marine invertebrates; their diversity and potential for applications in biotechnology.
Brown ER; Piscopo S
Biotechnol Adv; 2011; 29(5):457-67. PubMed ID: 21620946
[TBL] [Abstract][Full Text] [Related]
25. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
Dunlop J; Bowlby M; Peri R; Vasilyev D; Arias R
Nat Rev Drug Discov; 2008 Apr; 7(4):358-68. PubMed ID: 18356919
[TBL] [Abstract][Full Text] [Related]
26. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
Thorneloe KS
IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
[TBL] [Abstract][Full Text] [Related]
27. HTS assays for developing the molecular pharmacology of ion channels.
McManus OB
Curr Opin Pharmacol; 2014 Apr; 15():91-6. PubMed ID: 24556186
[TBL] [Abstract][Full Text] [Related]
28. Ion channels as potential targets for the treatment of depression.
Lodge NJ; Li YW
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):633-41. PubMed ID: 18729015
[TBL] [Abstract][Full Text] [Related]
29. Ion channels in membranes.
Katz AM; Messineo FC; Herbette L
Circulation; 1982 Jan; 65(1 Pt 2):I2-10. PubMed ID: 6273012
[TBL] [Abstract][Full Text] [Related]
30. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
Brake AJ; Wagenbach MJ; Julius D
Nature; 1994 Oct; 371(6497):519-23. PubMed ID: 7523952
[TBL] [Abstract][Full Text] [Related]
31. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
Krishek BJ; Moss SJ; Smart TG
Mol Pharmacol; 1996 Mar; 49(3):494-504. PubMed ID: 8643089
[TBL] [Abstract][Full Text] [Related]
32. Marine snail venoms: use and trends in receptor and channel neuropharmacology.
Favreau P; Stöcklin R
Curr Opin Pharmacol; 2009 Oct; 9(5):594-601. PubMed ID: 19540804
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in electrophysiology-based screening technology and the impact upon ion channel discovery research.
Southan A; Clark G
Methods Mol Biol; 2009; 565():187-208. PubMed ID: 19551363
[TBL] [Abstract][Full Text] [Related]
34. Essential oils components as a new path to understand ion channel molecular pharmacology.
de Araújo DA; Freitas C; Cruz JS
Life Sci; 2011 Oct; 89(15-16):540-4. PubMed ID: 21620870
[TBL] [Abstract][Full Text] [Related]
35. The TRPM ion channel subfamily: molecular, biophysical and functional features.
Fleig A; Penner R
Trends Pharmacol Sci; 2004 Dec; 25(12):633-9. PubMed ID: 15530641
[TBL] [Abstract][Full Text] [Related]
36. Validation of ion channel targets.
Gerlach AC; Antonio BM
Channels (Austin); 2015; 9(6):376-9. PubMed ID: 26556675
[TBL] [Abstract][Full Text] [Related]
37. Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.
Varga Z; Hajdu P; Panyi G
Immunol Lett; 2010 May; 130(1-2):19-25. PubMed ID: 20026117
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of the ascidian genome reveals novel insights into the molecular evolution of ion channel genes.
Okamura Y; Nishino A; Murata Y; Nakajo K; Iwasaki H; Ohtsuka Y; Tanaka-Kunishima M; Takahashi N; Hara Y; Yoshida T; Nishida M; Okado H; Watari H; Meinertzhagen IA; Satoh N; Takahashi K; Satou Y; Okada Y; Mori Y
Physiol Genomics; 2005 Aug; 22(3):269-82. PubMed ID: 15914577
[TBL] [Abstract][Full Text] [Related]
39. Exploiting high-throughput ion channel screening technologies in integrated drug discovery.
Treherne JM
Curr Pharm Des; 2006; 12(4):397-406. PubMed ID: 16472135
[TBL] [Abstract][Full Text] [Related]
40. Advantages of voltage-gated ion channels as drug targets.
McGivern JG
Expert Opin Ther Targets; 2007 Mar; 11(3):265-71. PubMed ID: 17298286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
